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Abstract
The gammaherpesviruses, including Epstein-Barr virus (EBV) and Kaposi’s sarcoma-associated herpesvirus (KSHV), establish
latency in memory B lymphocytes and promote lymphoproliferative disease in immunocompromised individuals. The
precise immune mechanisms that prevent gammaherpesvirus reactivation and tumorigenesis are poorly defined. Murine
gammaherpesvirus 68 (MHV68) is closely related to EBV and KSHV, and type I (alpha/beta) interferons (IFNab) regulate
MHV68 reactivation from both B cells and macrophages by unknown mechanisms. Here we demonstrate that IFNb is highly
upregulated during latent infection, in the absence of detectable MHV68 replication. We identify an interferon-stimulated
response element (ISRE) in the MHV68 M2 gene promoter that is bound by the IFNab-induced transcriptional repressor IRF2
during latency in vivo. The M2 protein regulates B cell signaling to promote establishment of latency and reactivation. Virus
lacking the M2 ISRE (ISRED) overexpresses M2 mRNA and displays uncontrolled acute replication in vivo, higher latent viral
load, and aberrantly high reactivation from latency. These phenotypes of the ISRED mutant are B-cell-specific, require IRF2,
and correlate with a significant increase in virulence in a model of acute viral pneumonia. We therefore identify a
mechanism by which a gammaherpesvirus subverts host IFNab signaling in a surprisingly cooperative manner, to directly
repress viral replication and reactivation and enforce latency, thereby minimizing acute host disease. Since we find ISREs 59
to the major lymphocyte latency genes of multiple rodent, primate, and human gammaherpesviruses, we propose that
cooperative subversion of IFNab-induced IRFs to promote latent infection is an ancient strategy that ensures a stable,
minimally-pathogenic virus-host relationship.
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Introduction
The gammaherpesviruses (cHVs)establish life-long latent infection
in memory B lymphocytes. The human cHVs Epstein-Barr virus
(EBV) and Kaposi’s sarcoma-associated herpesvirus (KSHV) are the
causes of infectious mononucleosis and Kaposi’s sarcoma (KS),
respectively [1,2]. cHV latency is a cofactor in the development
of lymphomas, sarcomas, and carcinomas. Viral reactivation and
neoplasms increase in immune compromised individuals, highlight-
ing the need for immune surveillance to prevent severe disease [2].
Mechanisms of immune control of latent EBV and KSHV are not
completely understood due to their human-specific host range.
Murine gammaherpesvirus 68 (MHV68) is closely related to the
human cHVs and provides a genetic model to study cHV-immune
interactions that regulate pathogenesis [3,4].
We previously uncovered an unexpected role for type I (alpha/
beta) interferons (IFNab) during MHV68 latency [5]. IFNab are
a family of antiviral cytokines whose expression is triggered by
cellular sensors of viral nucleic acid that activate interferon regulatory
factor (IRF) family transcription factors [6]. IRFs bind to interferon
stimulated response elements (ISREs) in IFN gene promoters to
trigger expression of IFNab.I F N ab signaling via its heterodimeric
receptor (IFNAR1/2) induces a large family of interferon-stimulated
genes (ISGs) that inhibit viral replication by multiple mechanisms.
Once virus infection has been cleared, the IFNab-induced transcrip-
tional repressor IRF2 exerts a negative feedback role to terminate
IFNab expression and prevent inflammatory pathology [7]. Many
viruses antagonize IFNab expression or ISG function to maximize
replication [8]. However, the interactions between latent viruses and
IFNab are largely unexplored.
We found that mice lacking the IFNab receptor (IFNAR1-/-)
exhibit increased MHV68 reactivation from latency in both
splenic B cells and peritoneal macrophages [5]. This was
unexpected since viral molecules that trigger IFNab production
should be largely absent during latency, when infectious virus is
undetectable using classical virologic assays. In addition, known
PLoS Pathogens | www.plospathogens.org 1 November 2011 | Volume 7 | Issue 11 | e1002371antiviral functions of IFNab are critical during acute viral
infection, but are thought to be dispensable once replication is
controlled [6]. One clue to the mechanism of IFNab function
during MHV68 latency came from our observation that the
MHV68 latent gene M2 is specifically upregulated in splenocytes
from IFNAR1-/- mice [5]. M2 is required for establishment of
latency in splenic B cells following mucosal infection and is
essential for reactivation from B cells [9]. While the precise
function of M2 is not known, it interacts with B cell signaling
molecules including fyn and vav1, resulting in efficient entry of
infected B cells into a germinal center (GC) reaction [10–13]. This
suggests that M2 is a functional analog of the human cHV B cell
signaling mimics LMP2A and K1 of EBV and KSHV, respectively
[14]. M2 also promotes differentiation into plasma B cells, the
main cell type that supports reactivation of MHV68, EBV, and
KSHV [15]. Thus, M2 plays important roles in both establishment
of latency and reactivation. Upregulation of M2 in IFNAR1-/-
mice suggested that latency and reactivation are directly regulated
by IFNab-dependent modulation of M2 expression.
Here we show that latent MHV68 infection triggers sustained,
IFNab-driven expression of IRF2, which binds an ISRE present in
the M2 promoter. A mutant virus lacking the M2 ISRE (ISRED)
exhibits uncontrolled replication and increased host lethality late in
acute infection. During latency, ISRED overexpresses M2 mRNA,
and displays increased viral load and aberrantly high reactivation.
These phenotypes were absent in mice lacking B cells, IRF2, or
IFNAR1. Thus, we demonstrate that MHV68 subverts IFNab-
dependent IRF2 signaling to silence expression of a viral B cell
signaling mimic, thereby preventing viral replication and reactiva-
tion. This demonstrates that viral promoters can cooperate with
IFNab-induced host transcription factors to directly mediate the
antiviral effects of IFNab. To our knowledge, this is the first
example of viral cooperation with the IFNab system. We
hypothesize that evolution of IFNab-responsive viral promoters
provides a selective advantage, by curtailing replication and
expansion of the latently-infected reservoir prior to severe host
pathology, and by ensuring that reactivation occurs only when the
microenvironment of the latent cell favors productive replication.
Given the conservation of ISREs in latent promoters of EBV and
KSHV [16–18], we propose that this cooperative approach is a
general regulatory strategy that arose during cHV-host coevolution.
Results
IRF2 binds the M2 ISRE during latency in vivo
We found a consensus ISRE in the M2 intron (Figure 1A).
Functional intronic ISREs have been reported, suggesting that this
ISRE regulates the M2 promoter [19,20]. To determine whether
the M2 ISRE binds host IRFs, we incubated M2 ISRE probes
with nuclear proteins from splenocytes of latently-infected mice in
electromobility shift assays (EMSA). As a control, we mutated four
residues essential for IRF binding (ISRED, Figure 1A) [21]. M2
ISRE and M2 ISRED probes formed distinct complexes with
nuclear proteins (Figure 1B). Only complexes formed with M2
ISRE were specific, since formation was inhibited with excess
unlabeled M2 ISRE but not M2 ISRED probe (Figure S1). Two
different antisera specific for IRF2 super-shifted M2 ISRE-bound
complexes but not those bound to M2 ISRED (Figure 1B). IRF2 is
an essential component of these complexes, since they are not
formed using nuclear extracts from IRF2-/- mice (Figure 1C).
To determine whether IRF2 binds to M2 ISRE in vivo we used
chromatin immunoprecipitation (ChIP) from splenocytes of latent-
ly-infected mice (Figure 1D). Anti-IRF2 antisera enriched DNA
within one kilobase of the M2 ISRE, but not adjacent control
regions. Interestingly, in two of three experiments, we also detected
IRF2 binding to a region in the nearby M4 gene. Analysis of this
region revealed a second consensus ISRE (M4-ISRE, Figure 1D)
supporting the specificity of the assay. Thus, IRF2 binds the M2
ISRE during latent infection in the spleen.
IFNb and IRF2 are induced during MHV68 lytic and latent
infection
IRF2 is generally a transcriptional repressor, is constitutively
expressed at low levels in many cell types including lymphocytes,
and is upregulated by IFNab [21,22]. IFNAR1-/- mice display
increased reactivation and upregulation of M2 [5], suggesting that
IFNabinduces IRF2-dependent repression of M2 during latency.
However, others have reported that IFNabproteins are not
detectable during acute MHV68 infection in the lung [23].
Therefore, we determined kinetics of IFNband IRF2 expression
duringMHV68 infection in the spleen ofwildtype, IFNAR1-/-, and
IRF2-/- mice. Under these conditions, IRF2-/- mice experience
no lethality, clear acute infection, and establish latency with no
evidence of persistent lytic replication (not shown and Table 1).
IFNb and IRF2 transcripts were strongly induced in a time-
dependent fashion during acute infection (Figure 2A,D). Both
transcripts were more highly induced during latent infection (16–28
days post infection (dpi)) than at the peak of acute infection (4–
9 dpi). Full induction of both transcripts required IFNAR1
(Figure 2C,F), confirming that extracellular IFNab proteins are
produced and functional. Consistent with the repressive role of
IRF2, IFNb was significantly elevated during latent infection in
IRF2-/- mice (Figure 2B). These data demonstrate sustained
expression of IFNb and IRF2 at the major site of MHV68 latency.
M2 ISRE is not required for MHV68 replication or IFNab
sensitivity in vitro
We generated two independent mutant viruses lacking the
IRF contact residues in M2 ISRE (ISRED1 and ISRED2) and a
Author Summary
Herpesviruses establish life-long infection in a non-replicat-
ing state termed latency. During immune compromise,
herpesviruses can reactivate and cause severe disease,
including cancer. We investigated mechanisms by which
interferons alpha/beta (IFNab), a family of antiviral immune
genes, inhibit reactivation of murine gammaherpesvirus 68
(MHV68).MHV68isrelated toEpstein-Barr virusandKaposi’s
sarcoma-associated herpesvirus, human gammaherpes-
viruses associated with multiple cancers. We made the
surprising discovery that during latency, MHV68 cooperates
with IFNab to inhibit its own replication. Specifically, a viral
gene required for reactivation has evolved to be directly
repressed by an IFNab-induced transcription factor, IRF2.
Once virus replication has triggered sufficient IFNab
production, expression of this viral gene is reduced and
reactivation efficiency decreases. This strategy safeguards
the health of the host, since a mutant virus that cannot
respond to IRF2 replicates uncontrollably and is more
virulent. Viral sensing of IFNab is also potentially subversive,
sinceitallowsMHV68todetect periods oflocalizedimmune
quiescence during which it can reactivate and spread to a
new host. Thus, we highlight a novel path of virus-host
coevolution, toward cooperative subversion of the antiviral
immune response. These observations may illuminate new
targets for drugs to inhibit herpesvirus reactivation or
eliminate herpesvirus-associated tumors.
IRF2 Directly Promotes Gammaherpesvirus Latency
PLoS Pathogens | www.plospathogens.org 2 November 2011 | Volume 7 | Issue 11 | e1002371Figure 1. The M2 ISRE binds IRF2 in vivo during latency. (A) The M2 locus indicating the location of the consensus ISRE. M2 ISRE sequence (nt.
4603-4632 of GenBank Accession U97553.2) and ISRED mutations (boxed bases) are shown. Consensus ISRE sequence is based on reference [21]. The
location of the basal M2 promoter is based on reference [20]. (B) Nuclear extracts from splenocytes of latently-infected C57BL6/J mice were
incubated with radiolabeled M2 ISRE or M2 ISRED probes to detect M2 ISRE binding proteins via EMSA (shifted complexes). Two different antisera
against IRF2 (H229X, C19) were used to detect complexes containing IRF2 (Ab-supershifted complexes). See Figure S1, which demonstrates specificity
of complexes bound to M2 ISRE probe. (C) Nuclear extracts from splenocytes of uninfected IRF2-/-, IRF2+/- or IRF2+/+ littermates were used in EMSA.
WT, nuclear extract from latently-infected C57BL6/J splenocytes. (D) Splenocytes harvested from latently-infected 129S2 mice were used to detect
IRF2 binding to the M2 ISRE via ChIP. Antiserum against IRF2 was used to precipitate crosslinked, sheared chromatin, which was subjected to PCR
amplification. Relative locations of the M2 ISRE PCR amplicon and control amplicons are shown. Input control PCR reactions were performed with
10% total chromatin removed prior to immunoprecipitation. Control precipitations performed without anti-IRF2 antibody yielded no amplicons for
any primer set (not shown). Shown are results from three independent experiments using pooled splenocytes from three to five mice per experiment.
MWM, molecular weight marker.
doi:10.1371/journal.ppat.1002371.g001
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PLoS Pathogens | www.plospathogens.org 4 November 2011 | Volume 7 | Issue 11 | e1002371repairedmarkerrescue(MR)virus(Figure3A,B).ISRED1r e p l i ca t i o n
was identical to MHV68 in murine embryonic fibroblasts (MEFs)
(Figure 3C,D) or bone marrow-derived macrophages (BMM)
(Figure 3E,F), and ISRED1 replication was inhibited normally by
pretreatment of cells with IFNb (Figure 3D,F). Thus, the M2 ISRE is
not required for viral replication or inhibition by IFNb in vitro.
The M2 ISRE represses MHV68 replication at late time
points of acute infection in wildtype but not IFNAR1-/-
mice
To determine whether the M2 ISRE regulates acute infection in
vivo, we infected mice with MHV68 and ISRED1 and quantified
viral titer in lung and spleen (Figure 4). At 4 dpi, replication of
MHV68 and ISRED1 in lungs of wildtype mice of two genetic
backgrounds was identical, indicating that the M2 ISRE is not
required for early acute infection. In contrast, at 9 dpi, we
observed a 20- to 30-fold increase of ISRED1 replication in both
lung and spleen (Figure 4A,D,G,J). Increased replication of
ISRED1 persisted at 12 dpi (3- to 7-fold upregulated), but no
infectious virus of either strain was detectable in spleen at 16, 21,
or 28 dpi, indicating that clearance of ISRED1 acute infection is
not delayed (See Methods). Increased replication of ISRED1 was
specific for the ISRED mutation, since it was observed during
infection with ISRED2 and was restored to MHV68 levels in MR
virus infection (Figure S2). Thus the M2 ISRE represses viral
replication at late times of acute infection, suggesting that deletion
of M2 ISRE allows MHV68 to bypass some component of the host
response. To test whether the host control mechanism uncovered
by M2 ISRE deletion requires IFNab, we compared MHV68 and
ISRED1 replication in IFNAR1-/- mice. Replication of both
MHV68 and ISRED1 was significantly upregulated in IFNAR1-/-
mice compared to wildtype mice, but in the absence of IFNAR1
no difference in replication of MHV68 and ISRED1 was observed
(Figure 4B,E,H,K). As a control for specificity of the IFNAR1
signaling pathway, we infected mice lacking the IFNc receptor
(IFNGR1-/-). These mice displayed increased early replication
(4 dpi), but no difference was observed between MHV68 and
ISRED1 at this time point. However, as observed in wildtype
mice, replication of ISRED1 was increased 15- to 30-fold at 9 dpi
in lung and spleen of IFNGR1-/- mice, and remained elevated 6-
to 17-fold at 12 dpi (Figure 4C,F,I,L). Thus, the M2 ISRE
functions as a repressor of MHV68 replication at late times of
acute infection, and acts by a mechanism that seems to require
functional IFNab, but not IFNc, signaling. However, it is possible
that the high level of replication of both viruses in IFNAR1-/-
mice may obscure the contribution of the M2 ISRE to replication.
Repression of acute MHV68 replication by M2 ISRE
requires IRF2 and B cells
Since IFNab likely controls MHV68 replication by multiple
mechanisms, we quantified replication of MHV68 and ISRED in
IRF2-/- mice as a more specific test of the requirement of IFNAR1-
dependent signaling in regulating MHV68 replication via the M2
ISRE. While the replication of ISRED1 was increased ,100-fold
relative to MHV68 in IRF2+/+ mice, in IRF2-/- littermates
MHV68 replication and lytic gene expression rises precisely to the
level of ISRED1, and the two viruses are statistically identical
(Figures 5A,B). Importantly, titers in IRF2-/- mice are .10-fold
lower than the maximum observed in IFNAR1-/- mice
(Figure 4B,E,H,K), suggesting that IRF2-independent increases in
replication of ISRED virus should be evident if they existed. The
absence of increased replication of ISRED in IRF2-/- mice suggests
that the M2 ISRE functions solely in response to IFNab-dependent
IRF2 to decrease replication. The observation that ISRED1
replicates at higher levels than MHV68 during acute infection
was unexpected, since M2 is dispensable for acute replication in vitro
and in vivo [9]. All known functions of M2 are B-cell-specific and
include inducing B cell entry into and egress from the GC reaction,
and triggering B cell differentiation into plasma cells, the
predominant cell type supporting viral reactivation in vivo [10,15].
However, latently-infected B cells are detectable in the lung early
during acute MHV68 infection [24]. Thus, we reasoned that
Figure 2. IFNb and IRF2 are upregulated during acute infection and latency in vivo. Total RNA was harvested from splenocytes of mice
infected with MHV68 at the indicated times post infection. Quantitative RT-PCR was used to detect spliced transcripts of IFNb (A–C) or IRF2 (D–F).
Indicated are the mouse genotypes from which RNA was harvested: 129S2, IRF2-/- (C57BL6/J background), IFNAR1-/- (129S2 background). Expression
of IFNb or IRF2 transcripts is shown as fold induction relative to background-matched uninfected wildtype mice at the same time post infection.
Expression in 129S2 and IFNAR1-/- mice is normalized to uninfected 129S2 mice and expression in IRF2-/- mice is normalized to uninfected IRF2+/+
littermates. Shown are mean (+/- SEM) from three pooled independent experiments with two to three mice per group. *p# 0.05, **p# 0.01, ***p#
0.001, ****p# 0.0001 by paired, two-tailed t-test. For A and D, p values represent comparison of transcript levels to uninfected 129S2 mice. For B and
F, p values represent comparison of transcript levels to infected IRF2+/+ littermates or infected 129S2 mice, respectively, at the same time points. N.S.,
nonspecific (p.0.05). N.D., not detected.
doi:10.1371/journal.ppat.1002371.g002
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PLoS Pathogens | www.plospathogens.org 6 November 2011 | Volume 7 | Issue 11 | e1002371increased replication of ISRED during late acute infection may be
due to premature reactivation in infected B cells. To test this
hypothesis,we infected B cell deficient mice(mMT-/-) with MHV68
and ISRED1 and quantified replication (Figure 5C,D). MHV68
replication increased approximately 20-fold in mMT-/- mice, which
we speculate may be due to redirection of MHV68 virions to a
purely lytic infection in the absence of B cells as targets for latency.
Alternatively, B cells may exert an indirect antiviral effect on
MHV68 replication. However, this effect must still require the M2
ISRE for function since ISRED replication is identical in wildtype
and mMT-/- mice. ISRED1 replication was indistinguishable from
MHV68 replication in lungs of mMT-/- mice at 4, 9, and 12 dpi
(Figure 5D and data not shown). Neither MHV68 nor ISRED1
virus was detected in spleen of mMT-/- mice, consistent with a
criticalroleforB cellsinspread([25] and data notshown).Thus,the
increased replication phenotype of ISRED1 requires B cells,
suggesting that newly infected B cells require IFNAR1- and IRF2-
dependent repression of M2 expression to prevent premature viral
reactivation.
M2 ISRE specifically represses M2 expression during
latency via an IRF2-dependent mechanism
To determine if the M2 ISRE regulates M2 expression during
latency, we quantified M2 mRNA in spleens at times when lytic
replication is absent (Figure 6). M2 mRNA was significantly
upregulated at both early (16 dpi) and later (28 dpi) times during
latent ISRED1 infection (Figure 6A–C). Upregulation was specific
for M2 mRNA and was not observed for viral M3 or M9 transcripts
(Figure6D–I).Importantly,inIRF2-/-miceM2transcriptexpressed
by MHV68 increased precisely to the level observed in ISRED1
infection, while M3 and M9 expression efficiency were unaltered.
Thus, M2 expression is specifically repressed during latency by an
M2 ISRE- and IRF2-dependent mechanism. When we compared
the kinetics of IFNb, IRF2, and M2 expression in the spleen, we
detected elevated IFNb and IRF2 mRNA in spleen by 4 dpi (Figure
S3). At this timepoint no M2 mRNA is detectable, likely because
virus has not yet reached the spleen (Figure 4). From 9–28 dpi with
MHV68, M2 mRNA is present in the spleen at a low but constant
level. In contrast, M2expression is upregulated ,3–4-fold at all time
points in ISRED infection, indicating that the M2ISRE reduces, but
does not completely silence, M2 expression (Figure S3). Thus, our
data indicate that M2 expression is controlled by at least two
promoter elements: a 59 promoter proximal to the transcription start
site [20] and the intronic ISRE we report here (Figure 1).
M2 ISRE represses reactivation from splenic cells but not
peritoneal cells
M2 overexpression is sufficient to drive viral reactivation from
plasmaBcells[15].TodeterminewhetherrepressionofM2byIRF2
decreases MHV68 reactivation, we performed ex vivo reactivation
assays with splenocytes and peritoneal exudate cells (PECs) from
mice infected with MHV68, ISRED1, or ISRED2 (Figure 7, Figure
S4, Table 1). Splenocytes from wildtype mice infected with either
ISRED1o rI S R E D2 showed a significant four-fold increase in
reactivation compared to MHV68 at both 16 and 28 dpi (Table 1
and Figure 7A,C). At 16 dpi, increased reactivation was solely
attributable to increased reactivation efficiency, since the frequency
of latently-infected cells was equivalent (,1:1400) in mice infected
with either virus. However, at later times, increased reactivation
during ISRED infection was a composite effect of both increased
numbers oflatently-infected cells(Figure S4) and increased efficiency
of reactivation (Table 1). Increased reactivation efficiency of ISRED
required IFNAR1 and IRF2, since in IFNAR1-/- and IRF2-/- mice
MHV68 and ISRED mutant viruses reactivated with identical
frequencies that are increased relative to those observed in MHV68-
infected wildtype mice (Figure 7B–D, Table 1). Importantly, in this
assay,,10%of latently-infected cellsreactivate(Table 1),permitting
sufficient upwarddynamicrangefor IFNAR1-independent orIRF2-
independent effects of the M2 ISRE to be observable if they existed.
Increased reactivation of ISRED is likely B cell-specific, since
reactivation of MHV68, ISRED1, and ISRED2f r o mP E C sw a s
identicalunderall conditions(Table1 and Figure 7E–H). The major
latent cell in the spleen is the B cell, while in PECs most latent virus
resides in macrophages [26]. Taken together, these genetic data
strongly suggest that MHV68 reactivation from B cells is repressed
by IFNab-driven, IRF2-mediated repression of M2 expression,
acting through the M2 ISRE.
M2 ISRE attenuates MHV68 virulence. The increased
replication and reactivation of ISRED relative to MHV68 suggested
that the M2 ISRE may function to minimize host pathology during
acute infection. To test this hypothesis, we infected IFNc-/- mice on
a BALB/c background, which succumb to acute lethal MHV68
pneumonia [27]. Following intranasal infection, ISRED-infected
IFNc-/- mice showed significantly increased lethality compared
to mice infected with MHV68 (Figure 8). Thus, the M2 ISRE
functions to attenuate acute MHV68 infection, likely by acting to
reduce viral replication in response to IFNab-induced IRF2.
Discussion
We have uncovered a previously unappreciated mode of
interaction between viruses and IFNab: rather than evading this
antiviral system, MHV68 directly cooperates with it to silence
replication during establishment of latency. This strategy relies on
IFNab-induced IRF2 to regulate critical cell differentiation
decisions following viral infection of B cells (Figure 9). Shortly
after B cell infection, the M2 ISRE is either unoccupied or may be
bound by transactivating IRFs (IRF’’X’’, Figure 9A). M2
expressed at this time drives B cells into a GC reaction, resulting
in expansion of latently-infected memory and plasma cells. As
replication peaks, IFNab induces IRF2, which binds the M2 ISRE
and represses M2 transcription. M2 silencing would decrease entry
of infected B cells into the GC (Figure 9B), reducing overall latent
Figure 3. Generation and characterization of MHV68 lacking the M2 ISRE (ISRED). (A) BAC-mediated mutagenesis was used to generate
MHV68-ISRED virus. A portion of the M2 intron and the entire M2 second exon were replaced with a kanamycin-resistance cassette (M2-Kan) to
permit facile identification of recombinants incorporating the M2 ISRED (ISRED) mutation in a second round of recombination. KanR, kanamycin
resistance cassette. M1, M2, and M3 are MHV68 genes. BAC, bacterial artificial chromosome vector sequences. SpeI restriction sites (S) are indicated.
SpeI digest of MHV68, MR, and ISRED are predicted to yield fragments of 7.2 and 4 kb in the mutagenized locus, while M2-Kan yields fragments of 6.4
and 5.2 kb. Dashed line indicates the maximum possible regions exchanged during homologous recombination between M2-flanking homology
arms (HA) (B) Characterization of two independent ISRED mutants (ISRED1 and ISRED2) and a genetically restored marker rescue (MR) construct
derived from ISRED1. Purified BAC DNA was digested with SpeI and resolved by agarose gel electrophoresis. (C–F) Murine embryonic fibroblasts
(MEFs, (C, D)) or bone marrow-derived macrophages (BMMs, (E, F)) from 129S2 mice were either untreated (C, E) or treated with 500 U/ml IFNb (D,
F) for 18 hours prior to infection with MHV68 or ISRED1 at a multiplicity of infection of 0.1 PFU per cell. At the indicated time post infection, cultures
were disrupted by freezing and thawing and infectious virus quantified by plaque assay. Shown are mean (+/- SEM) of three independent
experiments for each group.
doi:10.1371/journal.ppat.1002371.g003
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PLoS Pathogens | www.plospathogens.org 7 November 2011 | Volume 7 | Issue 11 | e1002371load [10]. M2 is sufficient to promote differentiation into plasma
cells [15] and the majority of viral reactivation is derived from
plasma cells [15]. Thus, IRF2-dependent M2 repression is also
expected to decrease reactivation. When we perturb this
regulatory switch using either IRF2-/- mice or ISRED virus, the
result is a substantial increase in viral replication during late acute
infection (Figure 4), which we attribute to premature reactivation
from newly infected B cells (Figure 5) driven toward plasma cell
differentiation by overexpression of M2 (Figure 6). This increase in
reactivation is still evident during ISRED latency, and results in
increased latent load over time (Figure 7). Additional IFNab-
dependent mechanisms exist to control MHV68 replication and
reactivation, since the M2 ISRED mutation does not fully
recapitulate the dysregulation of these processes observed in
IFNAR1-/- mice [5]. While the simplest mechanism that is
consistent with our genetic and biochemical data involves IFNab-
induced IRF2 binding to the M2 ISRE to reduce M2 expression in
infected B cells during latency expansion in the spleen, other
interpretations are possible. For example, it is also conceivable that
B cells and IRF2 exert M2 ISRE-dependent control of viral
replication and reactivation in a trans-acting manner, rather than
directly in the infected B cell.
We propose the term ‘‘cooperative subversion’’ to describe this
regulatory approach. The cooperative nature of the strategy is
evident by the lack of IFNAR1-dependent inhibition of ISRED
replication we observe late in acute infection (Figure 4), which
correlates with increased lethality in a moderately immune
compromised (IFNc-/-) host (Figure 8). This indicates that a
primary function of the M2 ISRE is to reduce viral replication in
cooperation with the host IFNAR1 signaling pathway. To our
Figure 4. The M2 ISRE represses lytic replication in vivo via a mechanism that requires IFNAR1. Mice of the indicated genotype on either
a 129S2 (A–F) or C57BL6/J background (G–L) were infected with MHV68 (solid line) or ISRED1 (dashed line) and lung and spleen harvested 4, 9, 12,
or 21 dpi. Infectious virus was quantified by plaque assay. Shown are mean viral titers (+/- SEM) from three pooled independent experiments with
three to five mice per group. Dashed line indicates the limit of detection. See Figure S2 for control experiments with ISRED2 and MR virus
demonstrating that increased replication is specific for the ISRED mutation. *p#0.05, **p#0.01, ***p#0.001, ****p#0.0001 by paired, two-tailed t-test
comparing ISRED to MHV68 in the same host strain at the same time point. Where not indicated, p.0.05.
doi:10.1371/journal.ppat.1002371.g004
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PLoS Pathogens | www.plospathogens.org 8 November 2011 | Volume 7 | Issue 11 | e1002371knowledge this is the first element identified in a herpesvirus
genome that directly engages a host ISG to decrease viral
replication. We hypothesize that this mechanism provides a
developmental switch to MHV68: once it has established a latent
load that assures life-long persistence, viral gene expression shifts
to a pattern that will prevent host pathology and lethality,
minimize the risk of B cell transformation, and reduce viral
antigen presentation. This also provides a potential strategy for
cHVs to target reactivation to periods of localized immune
quiescence during long-term latency, by permitting high level M2
expression only in microenvironments where IFNab secretion has
decreased, when replication is more likely to be productive. Thus,
we believe this mechanism is simultaneously cooperative and
subversive, but must be contrasted with overt IFNab evasion
strategies that are well documented during lytic infection with
many viruses [8].
The cHVs are uniquely suited to cooperation with the host
immune response. They need minimal replication to establish
latency, and instead rely on virus-driven proliferation of B cells to
seed the host. Indeed, the frequency of MHV68 latency is
independent of inoculum dose [28], and replication-defective
MHV68 can establish latent infection [24,29]. cHVs can rely on
lifelong transmission to spread to a new host, obviating the need
for high-level persistent replication; asymptomatic reactivation at
mucosal surfaces is instead the rule [30]. Since cHVs rely on the
health of the host to promote spread, it is likely a selective
advantage for them to cooperate with the host immune response to
prevent unbridled amplification of latent B cells and predisposition
of the host to neoplasia. Consistent with this hypothesis, there is
evidence that the dominant T cell epitopes of EBV are selected for
conservation, rather than evasion [31]. Our data demonstrate that
cooperation with innate antiviral cytokines may also function
during acute and latent infection. Whether this attenuating,
cooperative effect of the M2 ISRE is the primary function selected
during virus-host coevolution is not directly discernable from our
studies.
We found unexpectedly high-level IFNb expression during
latency, at times where we detect no infectious virus (Figure 2). In
subsequent studies, we found IFNb-producing cells in the spleen of
latent mice at 48 dpi, and significant upregulation of ISGs at
90 dpi (data not shown, manuscript in preparation). It is not clear
what viral triggers or host sensors lead to this sustained IFN
production. However, these data demonstrate that the IFNab-
driven response is not limited to acute infection, but extends well
into latency. Our data also indicate that host genes may not
directly mediate all ‘‘antiviral’’ effects of IFNab, but that viral
elements may be required to repress replication in response to
IFNab. By 28 dpi, nearly half of the antiviral effect of IFNab in
Figure 5. Increased replication of ISRED requires IRF2 and B cells. Mice of the indicated genotype were infected with MHV68 or ISRED1
intranasally, indicated organs harvested 9 dpi, and infectious virus quantified by plaque assay. Titers present in lung (A) or spleen (B) of IRF2+/+ or
IRF2-/- littermates are shown from two independent experiments. Titers present in lung of C57BL6/J (C) or B cell deficient (mMT-/-) (D) mice (on a
C57BL6/J background) are shown from three to six independent experiments. Dashed line indicates the limit of detection. Shown are mean (bar) and
individual viral titers from pooled experiments with three to five mice per group. Dashed line indicates the limit of detection. **p#01, ***p#0.001, by
paired, two-tailed t-test comparing ISRED to MHV68 in the same host strain at the same time point. N.S., not significant (p.0.05).
doi:10.1371/journal.ppat.1002371.g005
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PLoS Pathogens | www.plospathogens.org 9 November 2011 | Volume 7 | Issue 11 | e1002371the spleen is mediated by the M2 ISRE, since MHV68
reactivation in IFNAR1-/- mice is upregulated 7.9-fold yet
deletion of the M2 ISRE alone upregulates reactivation 3.7-fold
(Table 1, 129S2 background, 28 dpi). Interestingly, the M2 ISRE
has no apparent function during latency in peritoneal macro-
phages, a cell type where latency and reactivation are also
independent of M2 (Figure 7) [9]. This confirms that the ISRED
mutation does not dysregulate latency and reactivation in all cell
types, and indicates that IFNAR1-dependent pathways active in
latent macrophages remain to be defined.
Our data indicate a novel, direct antiviral function for IRF2
during cHV latency. Although IRF2-/- mice have immune defects
that disrupt control of some acute viral infections [7,32–34], they
clear MHV68 replication, establish latency at frequencies nearly
identical to IRF2+/+ littermates, and regulate viral reactivation
from the peritoneal compartment normally. This indicates that the
immune modulatory functions of IRF2 are not essential for an
effective response to MHV68 infection. In IRF2+/+ littermates,
ISRED virus replicates to 100-fold higher titer in the lung,
expresses significantly more M2 mRNA, and reactivates with
enhanced efficiency relative to MHV68. Importantly, we found
that MHV68 replication, M2 expression, and reactivation rises
precisely to that of ISRED in IRF2-/- mice (Figures 5,6,7, Table 1).
Thus, the M2 ISRE can only repress M2 expression and restrain
MHV68 replication and reactivation in a host that expresses IRF2.
This confirms that these phenotypes are not the result of
generalized immune defects during latency in IRF2-/- mice, but
almost certainly require the interaction between IRF2 and the M2
ISRE observed in Figure 1. Since IRF2 has oncogenic properties
[35], our data raise the question of whether cHV-induced IRF2
may play a tumor-promoting role during cHV latency.
Our data indicate that M2 expression is regulated by two
distinct promoter elements. The first identified M2 promoter is
located 59 to the M2 transcription initiation site, is functional in
murine B cells, and binds undefined transcription factors [20].
Our data indicate that the M2 ISRE can decrease the firing rate of
this 59 promoter when it is occupied by IRF2. IRF2 generally
functions as a transcriptional repressor, but its function is
modulated by several posttranslational modifications, including
proteolysis (which exposes a transcriptional transactivation do-
main) [36], sumoylation [37], acetylation [38], phosphorylation
[39], and interaction with other IRFs and co-factors [40]. The
modification state of IRF2 and levels of other IRFs that compete
for binding to the M2 promoter is likely to be dynamically
regulated. Importantly, IRF2 binding to the M2 ISRE does not
completely silence the M2 locus, thereby allowing expression of
Figure 6. The M2 ISRE requires IRF2 to represses M2 transcript levels during latency in vivo. Total RNA was harvested from splenocytes of
129S2 or IRF2+/+ and IRF2-/- littermate mice. Viral RNAs encoding M2 (A–C), M3 (D–F), or M9 (G–I) were detected using quantitative RT-PCR. Viral
gene expression was normalized to cellular mRNA standard (HPRT) and subsequently to viral genome copy number (due to two-fold increases in
latently-infected cells present in ISRED infection at 28 dpi [Table 1]) and is expressed as fold increase relative to MHV68 infection in wildtype mice of
the appropriate genetic background. Shown are mean (+/- SEM) from three pooled independent experiments with three to five mice per group.
*p#0.05 by paired, two-tailed t-test, comparing ISRED to MHV68 in the same host strain at the same time point. Where not indicated, p.0.05. This
phenotype was confirmed using the ISRED2 virus (two independent experiments, data not shown). See Figure S3 that compares the kinetics of M2,
IFNb, and IRF2 expression in spleen of infected mice.
doi:10.1371/journal.ppat.1002371.g006
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PLoS Pathogens | www.plospathogens.org 10 November 2011 | Volume 7 | Issue 11 | e1002371reduced M2 levels in the face of the host IFNab response. We
speculate that during establishment and early expansion of latency,
IRF2-mediated reduction in M2 expression is required to prevent
untimely viral reactivation, which can be triggered directly by M2
overexpression [15].
A spatiotemporally regulated balance of IRFs likely determines
the expression of M2 at distinct stages of the MHV68 latent life
cycle. It is noteworthy that multiple intrinsic and extrinsic stimuli
that induce cHV reactivation activate IRFs. Toll-like receptor
(TLR) stimulation with multiple viral and bacterial molecules
triggers reactivation of KSHV and MHV68 [41,42]. IRFs that are
activated downstream of TLR stimulation include IRFs 1, 3, 5,
and 7 [43,44]. In addition, DNA damage both activates IRF5 and
induces MHV68 reactivation [45,46]. These data suggest that
TLR- or stress-induced IRF activation may serve to displace IRF2
from the M2 ISRE, inducing M2 expression and reactivation.
However, there is no evidence for a transactivator bound to the M2
ISRE at the time points we assess, since M2 transcript levels are
upregulated to the same extent when either the ISRE or IRF2 is
deleted (Figure 6). It has been reported that overexpression of M2
may impair IFNab-induced signaling pathways [47]. Although this
function has not been confirmed in lymphocytes expressing
physiologic levels of M2, this strategy may enable sustained M2
expression once reactivation is induced, by acting as a negative
Figure 7. The M2 ISRE requires IFNAR1 and IRF2 to represses viral reactivation from latent splenocytes. Splenocytes (A–D) and
peritoneal cells (E–H) were harvested from 129S2, IFNAR1-/- (129S2 background), IRF2+/+, or IRF2-/- littermate mice latently-infected (28–35 dpi) with
MHV68, ISRED1 or ISRED2. Viral reactivation was quantified using an ex vivo limiting dilution reactivation assay. Shown is mean (+/- SEM) viral
reactivation from at least three independent experiments with three to five mice per group. See Figure S4 for limiting dilution PCR analysis of viral
genome frequencies present in these samples. Dashed line indicates the point of 63% reactivation-positive wells as determined by non-linear
regression, which was used to calculate the frequency of cells reactivating (Table 1). Note that additional, higher dilutions of cells were plated in A to
permit direct interpolation of reactivation frequency of MHV68 in wildtype mice. Reactivation frequency of MHV68 in IRF2+/+ mice was extrapolated
as described in Table 1. **p#0.01 by Wilcoxon matched pairs test comparing ISRED to MHV68 in the same host strain. Similar results were obtained in
wildtype and IFNAR1-/- mice on a C57BL6/J background (Table 1).
doi:10.1371/journal.ppat.1002371.g007
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PLoS Pathogens | www.plospathogens.org 11 November 2011 | Volume 7 | Issue 11 | e1002371feedback loop to prevent IFNab-driven IRF2 expression and
silencing of M2 transcription during latency establishment or
reactivation.
Complex but poorly understood relationships exist between the
human cHVs and IRFs. KSHV encodes viral IRF homologs
(vIRFs) that modulate function of host IRFs [48,49]. vIRF3 is
expressed during KSHV latency, when it antagonizes IRF5 and
p53 and enhances transactivation by IRFs 3 and 7 [49,50], and is
required for latent cell proliferation and survival [51]. EBV
interacts with numerous IRFs to regulate latent promoters. IRF2
binds to the EBNA-1 Qp promoter during restricted latency
programs I and II [18,52]. Although IRF2 represses Qp in some
EBV-infected B cell lines [18], other reports indicate that it can
upregulate Qp-driven EBNA-1 expression [52,53]. In addition,
the promoter of EBV LMP1, a viral CD40 signaling mimic,
contains an ISRE and is induced by IRF7 and repressed by IRF5
(Table 2). The consequences of EBV and KSHV promoter-IRF
interactions for the infected cell in vivo are unknown.
Several of the IRFs implicated in regulating KSHV and EBV genes
(including IRFs 2, 5, and 7) are induced by IFNab [21]. Little
attention has been given to the possibility that IRF-induced or
-repressed EBV and KSHV latent gene expression may be responsive
Figure 8. The M2 ISRE attenuates MHV68 virulence. IFNc-/- mice
on a BALB/c background were infected intranasally with 4610
5 PFU of
MHV68 or ISRED1 and monitored for lethality daily. Shown is a result
from two independent experiments with five mice per experimental
group. Survival curve was generated using Kaplan-Meier analysis and
statistical significance (**p#0.01) was calculated using Log-Rank test.
doi:10.1371/journal.ppat.1002371.g008
Figure 9. Model for M2 ISRE regulation of MHV68 infection in vivo. (A) Following induction of IFNab expression during MHV68 infection,
IFNAR1-dependent signaling upregulates IRF2, which binds to the M2 ISRE and represses M2 transcription. Other IRFs (IRF ‘‘X’’) may serve as positive
or negative regulators of M2 expression during different stages of the viral life cycle. Specifically, activation of transcriptional activator IRFs
downstream of TLRs may regulate MHV68 reactivation. (B) IRF2-dependent M2 repression regulates the efficiency of latently-infected B cell entry into
the GC reaction, exit of latent cells from the GC, and differentiation into plasma B cells that can support reactivation. Repression of M2 expression by
IFNab-dependent IRF2 expression may provide a crucial mechanism for controlling proliferation and differentiation of latently-infected B cells and
timing viral reactivation to periods of localized immune quiescence. Additional IFNab-dependent but M2 ISRE/IRF2-independent mechanisms exist
for regulating MHV68 reactivation from both B cells and macrophages.
doi:10.1371/journal.ppat.1002371.g009
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PLoS Pathogens | www.plospathogens.org 12 November 2011 | Volume 7 | Issue 11 | e1002371to the inflammatory environment of the infected cell. We demon-
strate that a latent gene controlling B cell differentiation and
reactivation is repressed by IFNab. Interestingly, LMP1 and M2 are
located in homologous regions of the viral genome [3], and our work
here demonstrates that like LMP1, M2 is regulated by a conserved
ISRE. While the importance of IRF-mediated LMP1 regulation in vivo
is unknown, our data suggest that EBV-infected cells may utilize this
circuit to fine-tune the balance between latent B cell proliferation
and reactivation in response to host inflammation. Intriguingly, we
find consensus ISREs in the 59 regions of the major lymphocyte
immortalization genes of EBV, KSHV, the primate cHV herpesvirus
saimiri, and two newly sequenced rodent cHVs [54], suggesting that
subversion of host IRFs to regulate the switch between lytic and latent
infection is an evolutionarily ancient invention (Table 2). Future studies
with MHV68 will enable dissection of the dynamics of viral promoter/
IRF interactions that may permit rational intervention to manipulate
the balance between viral latency, reactivation, and oncogenesis.
Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. Mice were handled
according to all applicable institutional, state, and federal animal
care guidelines, under animal care protocols approved by the
Purdue University (animal welfare assurance #A3231-01, protocol
#06-115) and Wake Forest University Animal Care and Use
Committees (animal welfare assurance #A3391-01, protocol
#A11-007). Veterinary technicians or laboratory staff assessed
animal health at least once daily. Moribund mice were humanely
euthanized.
Cell culture, reagents, viruses and quantitation of viral
growth
All cells were maintained in DMEM containing 10% fetal
bovine serum (DMEM/10). MEFs were harvested from embry-
onic d15–18 129S2 and C57BL6/J mice. Bone marrow was
harvested from the femur of 129S2 mice and differentiated in vitro
to produce BMM [55]. Bone marrow was cultured for four days
on 100 mm polystyrene dishes in 10 ml endotoxin-free DMEM/
10 supplemented to contain 20% vol/vol L929 cell supernatant,
5% vol/vol horse serum, 2 mM L-glutamine, and 1 mM sodium
pyruvate. On day four of differentiation, 10 ml of endotoxin-free
DMEM/10 supplemented to contain 10% vol/vol L929 cell
supernatant, 5% vol/vol horse serum, 2 mM L-glutamine, and
1 mM sodium pyruvate was added to each plate. On day seven of
differentiation, cells were detached from dishes using PBS (Ca
2+/
Mg
2+-free, 1 mM EDTA) and scraping. Wildtype and recombi-
nant virus stocks were generated from wildtype MHV68
propagated as a bacterial artificial chromosome (BAC) [56]. To
generate infectious virus stocks, column-purified BAC DNA was
transfected into BALB/3T12 cells (ATCC CCL-164) stably
transduced with cre recombinase to permit deletion of bacterial
sequences. Viruses were passaged at low multiplicity of infection
for three generations in BALB/3T12-cre cells prior to use. Organs
were disrupted with 1 mm silica beads using a Minibeadbeater
16 (Biospec Products) in 1 ml DMEM/10. Viral titers were
determined by plaque assay on BALB/3T12 monolayers [5].
Viral growth curves
For in vitro growth curves, 6610
4 MEFs or BMM were plated in
48 well tissue culture treated plates. Immediately after plating,
MEFS were incubated with 500 U/ml rIFNb (PBL laboratories)
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PLoS Pathogens | www.plospathogens.org 13 November 2011 | Volume 7 | Issue 11 | e1002371overnight (,18 hours) prior to infection. BMMS were kept at
37uC for 24 hours prior to overnight treatment with IFNb. Cells
were infected with 0.1 plaque-forming units (PFU) MHV68 or
ISRED per cell in an inoculum volume of 0.1 ml DMEM/10 for
one hour at 37uC. Inocula were aspirated, cells were washed twice
with 37uC PBS, and incubated in DMEM/10. Plates were frozen
at 280uC at indicated time points. Plates were frozen and thawed
twice prior to plaque assay.
BAC mutagenesis and generation of recombinant viruses
Recombinant viruses were generated using BAC mediated
mutagenesis as described [56]. The M2 locus (nt. 3791–4700)
relative to Genbank Accession U97553.2, [3] was replaced with a
kanamycin resistance cassette to generate M2-Kan BAC. Two M2
homology arms (59 arm: nt 3301–3790, 39 arm: nt 4701–5201) were
amplified by PCR and cloned on either side of a kanamycin
resistance cassette in allelic exchange mating vector pGS284 to
generate pGS284/M2/Kan. MHV68 BAC was mated to pGS284/
M2/Kan by cross streak on LB agar plates, and the expected
genomic configuration of kanamycin-resistant clones (M2-Kan
BAC) arising from host strain intersections were confirmed using a
minimum of four restriction endonucleases that yield diagnostic
fragment lengths. M2-Kan BAC was mated to pGS284 containing
the entire M2locus (generated byPCR using 59 homology armsense
and 39 homology arm antisense primers) that was mutagenized via
PCR to encode the M2 ISRED mutations as indicated in Figure 1
(pGS284/M2/ISRED). Kanamycin sensitive recombinants were
identified by replica plating and expected genomic configuration
confirmed by restriction digest. Two independent ISRED mutant
clones were generated using independent stocks of wildtype MHV68
BAC. Mating of ISRED1 to pGS284/M2/Kan and subsequent
replacement of the M2 locus by mating to pGS284 containing the
wildtype M2 sequence generated a genetically repaired marker
rescue virus, M2-MR. All PCR amplified homology arms and
mutagenized sequences were confirmed by DNA sequencing over
the entire length of the construct, and resulting mutant viral BAC
DNA was directly sequenced to confirm incorporation or repair of
mutations. To generate infectious virus stocks, column-purified BAC
DNA (4 mg) was transfected using Fugene HD (Roche) into BALB/
3T12 cells that were stably transduced with cre recombinase to
permit deletion of the BAC backbone. BAC sequence elimination
wasconfirmed afterthreepassagesinBALB/3T12-creusing indirect
fluorescence for EGFP expressed from the BAC locus.
Mice and infections
Age- and sex-matched mice (7-12 weeks of age) were used for all
experiments. Wildtype, IFNAR1-/-, and IFNGR-/- mice on 129S2
(old designation, 129/SvPas) background have been described [57].
Wildtype, IFNAR1-/-, IFNGR-/- mice on C57BL6/J background
were obtained from Dr. Herbert Virgin (Washington University).
Dr.StephanieVogel(UniversityofMaryland)donatedIRF2-/-mice
on C57BL6/J background [58]. B cell deficient (mMT-/-) and
IFNc-/- BALB/c (strain C.129S7(B6)-Ifng
tm1Ts/J) were purchased
from Jackson laboratories and are the only genotypes used in this
study that were not derived from in-house breeding. Isoflurane-
anesthetized mice received 100 PFU intranasally in 40mLo f
DMEM/10. For viral pneumonia induction (Figure 8), IFNc-/-
BALB/c received 4610
5 PFU intranasally. Mice were humanely
euthanized in Isoflurane prior to tissue harvest.
EMSA and ChIP
Nuclear extracts were prepared from splenocytes of latently-
infected C57BL6/J mice 28–35 dpi using Pierce NE-PER kit and
protein concentration was determined using Bio-Rad RC/DC
Kit. For EMSA, probes used were
M2 ISRE: 59-TTACCTGAAAACGAAACCTCATCA-39
and M2 ISRED:5 9-TTACCTGGAACCTGAACCTCATCA-39.
32P-labeled complementary oligonucleotides were hybridized to
generate double stranded (ds) probes. Ds probes were separated
from free radiolabeled dUTP by size exclusion chromatography
using Sephadex G-50 columns (Roche). Radiolabeled, ds probes
were incubated with nuclear extracts and resolved on acrylamide
gel [59]. Five mg of protein was incubated in a reaction with 1X
binding buffer (40 mM KCl, 20 mM HEPES pH 7.6, 1 mM
MgCl2, 1 mM EGTA, 0.5 mM DTT), 0.32 mg/ml poly dI-dC
(Sigma-Aldrich), 0.02 mg/ml plasmid pgL4.10, 4 mM AMP
(Sigma-Aldrich) and 1610
5 cpm of radiolabeled probes in a total
volume of 12.5 ml at room temperature for 30 minutes. Complexes
were resolved on 6% nondenaturing acrylamide-20 mM TBE gel
at 4uC. For supershift, two mg of gel-shift certified antisera raised
against mouse IRF2 (Santa Cruz #H229 and #C19) were added
to gel shift reactions. For competition assays,
32P-labeled M2 ISRE
probe and nuclear extract were incubated with increasing
concentrations of ds unlabeled M2 ISRE or M2 ISRED probes.
Dried gels were exposed to storage phosphorimager plates and
images analyzed using Bio-Rad PDQuest software.
For ChIP, splenocytes (6610
7) from latently-infected 129S2 mice
were fixed in 1% formaldehyde, washed in PBS, and sheared using a
Misonix S3000 Sonicator. Resulting chromatin had an average
length of 500–1000 base pairs. Chromatin was incubated overnight
with two mg anti-IRF2 (H229, Santa-Cruz Biotech) and immuno-
precipitated with protein A/G sepharose. Immunoprecipitated DNA
was reverse-crosslinked, phenol/chloroform extracted, ethanol pre-
cipitated, and amplified using conditions, PCR primers, and thermal
cycling parameters detailed in Supporting Protocol S1. Control (no
antibody, or irrelevant rabbit antiserum) immunoprecipitated
chromatin yielded no amplicons for any primer set (not shown).
Quantitation of viral and host mRNA
Total RNA was isolated from intact organs (during lytic infection)
or erythrocyte-depleted splenocytes (during latent infection) by silica
bead disruption in Trizol (Invitrogen)and subjected to RNAcleanup
(Qiagen RNAeasy Kit) and DNAse treatment (Ambion Turbo
DNAse Kit). Total RNA (1.5 mg) was used for cDNA synthesis
(Invitrogen Superscript Kit) followed by real time PCR on an ABI
7300 using primers for host HPRT, IFNb,I R F 2o rv i r a lM 2 ,M 3 ,o r
M9 genes. The primers for housekeeping gene HPRT, IFNb, IRF2
or viral gene M2 span exon-intron junctions, and all amplicons were
resolved on agarose gel electrophoresis to confirm predicted size.
Amplicons for M2 were sequenced and confirmed that ISRED
mutations did not alter M2 splicing. M3 and M9 are unspliced viral
transcripts; parallel reactions performed in the absence of reverse
transcriptase indicated that samples were free from contaminating
viral genomic DNA. For quantitation of viral episome number,
DNA was harvested from erythrocyte-depleted splenocytes and
quantitative PCR analysis performed using primers specific to
GAPDH or v-cyclin (ORF72) genomic DNA. Detailed analysis and
normalization equations are described in Supporting Protocol S2.
Limiting dilution assay to quantify frequency of latently-
infected and reactivating cells
Frequencies of viral genome positive and reactivating cells were
determined as described [5]. Briefly, on the indicated day post
infection mice were euthanized and spleen and peritoneal exudate
cells (PECs) removed. Spleens were homogenized to single-cell
suspensions, erythrocytes hypotonically lysed, and cell viability and
concentration determined. Cells were serially diluted and plated
IRF2 Directly Promotes Gammaherpesvirus Latency
PLoS Pathogens | www.plospathogens.org 14 November 2011 | Volume 7 | Issue 11 | e1002371immediately on indicator MEFs for the purposes of assessing viral
reactivation or were cryopreserved in 10% DMSO.
To determine the frequency of cells reactivating lytic viral
replication, freshly explanted cells were serially diluted and plated
in 96-well tissue culture plates seeded with 10
4 C57BL6/J MEFs per
well. Twenty-four replicates of each cell dilution were plated. Cells
were co-cultured for 21 days, and viral reactivation was scored by
visual inspection for cytopathic effect (CPE). To control for possible
persistent lytic viral replication in vivo, the extent of preformed lytic
virus in explanted cell populations was quantitated by mechanical
disruption of parallel cell samples using 0.5 mm silica beads prior to
plating on indicator MEFs. Such mechanical disruption kills .99%
of cells but has minimal effect on infectious virus. Under the infection
conditions used in these experiments, no significant virus persistence
was observed in any genotype of mice infected with MHV68 or
ISRED viruses.
To determine the frequency of explanted cells that harbored viral
genome, cryopreserved cells were thawed, counted, and serially
diluted in 96-well thermal cycling plates. Cells were lysed by overnight
incubation with proteinase K. Single-copy-sensitivity nested PCR was
performed using primers specific for MHV68 ORF72. Amplicons
were visualized by agarose gel electrophoresis. Twelve replicates of
each cell dilution were analyzed in separate PCR reactions.
Statistical analysis
Statistical analyses and nonlinear regression were performed
using GraphPad Prism 5.0 (GraphPad Software, San Diego, CA).
Data from limiting dilution viral genome and viral reactivation
assays were fitted to a sigmoidal dose-response curve by nonlinear
regression to determine the concentration of explanted cells
required to achieve 63% viral DNA-positive PCR reactions or
CPE-positive reactivation wells. This cell number was defined
according to the Poisson distribution as the reciprocal frequency of
viral latency or viral reactivation, respectively, as listed in Table 1.
Supporting Information
Figure S1 M2 ISRE specifically binds to nuclear pro-
teins from latently infected mice. Nuclear proteins harvested
from splenocytes of latent C57BL6/J mice were incubated with
radiolabeled double-stranded M2 ISRE probe to detect M2 ISRE
binding proteins via EMSA (shifted complexes). Unlabeled M2
ISRE or M2 ISRED probes were used as competitors at the
indicated molar excess relative to labeled probes.
(TIFF)
Figure S2 Two independently generated ISRED mutant
viruses, but not MR virus, display enhanced replication
in vivo. 129S2 mice were infected with the indicated viruses and
at 9 dpi lungs (A) and spleens (B) were harvested and infectious
virus quantified by plaque assay. Shown are individual organ titers
and means (bar) from two to three independent experiments with
three mice per group. *p#0.05, **p#0.01, ***p#0.001, by paired
t-test comparing ISRED or MR to MHV68 in the same host strain
at the same time point.
(TIFF)
Figure S3 Comparison of M2, IFNb, and IRF2 expres-
sion kinetics in the spleen. Total RNA was harvested from
splenocytes of mice infected with MHV68 or ISRED at the
indicated times post infection. Quantitative RT-PCR was used to
detect spliced transcripts of M2 (A–C), IFNb (D–F) or IRF2 (G–
I). Indicated are the mouse genotypes from which RNA was
harvested: 129S2 or IRF2-/- (C57BL6/J background). Expression
of all transcripts is shown normalized to internal cellular HPRT
mRNA. When comparing these data to Figure 6, note that due to
high levels of transcriptionally silent viral DNA (within virions)
present during acute infection, M2 expression is not normalized to
viral genome levels in this figure. Shown are mean (+/- SEM) from
two to three pooled independent experiments with two to three
mice per group. *p#0.05, **p#0.01, ***p#0.001, by paired t-test
comparing ISRED to MHV68 at the same time point (B)o r
IRF2-/- to IRF2+/+ littermates at the same time point (C).
Statistical comparisons of IFNb and IRF2 expression (D–I) are
contained within Figure 2. N.D., not detected.
(TIFF)
Figure S4 Quantitation of latent virus genome frequen-
cies using limiting dilution PCR. Splenocytes (A–D) and
peritoneal cells (E–H) were harvested from 129S2, IFNAR1-/-
(129S2 background), IRF2+/+, or IRF2+/- mice latently infected
(28–35 dpi) with MHV68, ISRED1 or ISRED2. IRF2+/+ and
IRF2-/- mice were littermates. The frequency of latently infected
cells was quantified using limiting dilution, nested PCR for viral
genome as discussed in Methods. Viral genome frequency is
interpolated from the percentage of 12 replicate PCR reactions,
initiated with the indicated number of splenocytes, that are
positive for the viral DNA amplicon. Shown is the mean (+/-
SEM) of at least three independent experiments with three to five
mice per group. Dashed line indicates the point of 63% Poisson
distribution generated by non-linear regression used to calculate
the frequency of cells harboring viral genome (Table 1). *p#0.05
by Wilcoxon matched pairs test.
(TIFF)
Protocol S1 Chromatin Immunoprecipitation (ChIP).
(DOC)
Protocol S2 qRT-PCR for cellular and viral transcript
quantitation.
(DOC)
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